BENDAMUSTINE GEN bendamustine hydrochloride 25 mg powder for injection vial

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

bendamustine hydrochloride, Quantity: 25 mg

Dostupno od:

Luminarie Pty Ltd

Farmaceutski oblik:

Injection, powder for

Sastav:

Excipient Ingredients: mannitol

Administracija rute:

Intravenous, Intravenous Infusion

Jedinice u paketu:

1 vial

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C). Efficacy relative to first-line therapies other than chlorambucil has not been established.,Previously untreated indolent CD20-positive, stage III-IV Non-Hodgkin?s lymphoma, in combination with rituximab.,Previously untreated CD20-positive, stage III-IV Mantle Cell Lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,Relapsed/Refractory indolent Non-Hodgkin?s lymphoma.

Proizvod sažetak:

Visual Identification: white to off-white sterile lyophilized powder; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Status autorizacije:

Registered

Datum autorizacije:

2020-09-23